US Stock MarketDetailed Quotes

TCRT Alaunos Therapeutics

Watchlist

3.8087
-0.2713-6.65%

Close Jul 23 16:00 ET

6.10MMarket Cap-226P/E (TTM)

Alaunos Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

79.57%-1.92M

-3.11%-30.14M

-3.58%-7.39M

-3.73%-6.37M

14.47%-7M

-20.73%-9.38M

52.44%-29.23M

52.86%-7.13M

35.84%-6.15M

61.84%-8.19M

Net income from continuing operations

83.26%-1.68M

6.86%-35.14M

14.37%-7.84M

4.24%-8.48M

11.67%-8.77M

-2.66%-10.05M

52.09%-37.73M

22.34%-9.16M

61.07%-8.85M

56.19%-9.93M

Operating gains losses

----

0.00%7K

---5K

--2K

----

--7K

----

Depreciation and amortization

-99.71%2K

-16.09%2.32M

-65.27%241K

-1.74%679K

2.04%699K

1.02%696K

6.24%2.76M

-1.56%694K

2.67%691K

0.88%685K

Other non cash items

----

-0.52%1.33M

25.39%-1.1M

13.57%385K

-30.33%1.46M

54.76%585K

4,203.23%1.33M

-457.52%-1.47M

-0.29%339K

--2.09M

Change In working capital

73.16%-409K

-818.85%-6.25M

-241.42%-2.72M

-180.76%-701K

35.25%-1.31M

-1,655.10%-1.52M

-72.30%870K

131.51%1.92M

-91.12%868K

49.86%-2.02M

-Change in receivables

--0

-99.73%3K

-100.03%-1K

100.14%4K

---4K

-99.64%4K

-68.86%1.11M

626.75%2.91M

-147.60%-2.91M

--0

-Change in prepaid assets

526.53%307K

-256.52%-1.36M

-2,646.00%-1.27M

-193.21%-467K

100.00%334K

-67.11%49K

-90.56%867K

-96.76%50K

-72.56%501K

-93.61%167K

-Change in payables and accrued expense

50.42%-716K

-587.16%-4.76M

14.89%-2.41M

-110.14%-345K

-96.84%-561K

-47.80%-1.44M

93.23%-693K

62.57%-2.83M

65.68%3.4M

93.92%-285K

-Change in other current assets

----

281.68%500K

--0

--500K

----

-34.83%131K

--0

135.20%126K

-Change in other current liabilities

--0

-17.71%-638K

-46.42%965K

-214.40%-393K

46.89%-1.08M

30.00%-133K

-224.88%-542K

1,159.41%1.8M

47.70%-125K

-297.47%-2.03M

Cash from discontinued investing activities

Operating cash flow

79.57%-1.92M

-3.11%-30.14M

-3.58%-7.39M

-3.73%-6.37M

14.47%-7M

-20.73%-9.38M

52.44%-29.23M

52.86%-7.13M

35.84%-6.15M

61.84%-8.19M

Investing cash flow

Cash flow from continuing investing activities

797.41%1.35M

1,716.13%1.5M

107.14%1K

-136.84%-135K

20.69%-23K

94.19%-193K

74.09%-93K

96.22%-14K

96.96%-57K

Net PPE purchase and sale

--0

797.41%1.35M

1,716.13%1.5M

107.14%1K

-136.84%-135K

20.69%-23K

94.19%-193K

74.09%-93K

96.22%-14K

96.96%-57K

Cash from discontinued investing activities

Investing cash flow

--0

797.41%1.35M

1,716.13%1.5M

107.14%1K

-136.84%-135K

20.69%-23K

94.19%-193K

74.09%-93K

96.22%-14K

96.96%-57K

Financing cash flow

Cash flow from continuing financing activities

-384.88%-18.14M

-11.98M

-6.16M

-75.30%6.37M

4,655.91%8.47M

-108.45%-2.11M

Net issuance payments of debt

--0

-117.27%-18.11M

--0

---11.86M

---6.25M

-133.33%-8.33M

---6.25M

---2.08M

--0

Net common stock issuance

--0

-99.37%92K

--0

--92K

--14.68M

--14.72M

---45K

--0

Proceeds from stock option exercised by employees

----

--0

----

-97.97%21K

--0

----

Net other financing activities

----

---125K

--0

----

Cash from discontinued financing activities

Financing cash flow

--0

-384.88%-18.14M

--0

---11.98M

---6.16M

-75.30%6.37M

4,655.91%8.47M

-108.45%-2.11M

--0

Net cash flow

Beginning cash position

-88.56%6.06M

-30.32%53M

-76.92%11.94M

-69.48%18.32M

-45.16%37.43M

-30.32%53M

-33.91%76.05M

-43.59%51.75M

-21.81%60.01M

-31.78%68.26M

Current changes in cash

87.68%-1.92M

-103.55%-46.93M

-570.18%-5.88M

22.90%-6.37M

-131.89%-19.12M

-99.54%-15.56M

40.90%-23.06M

107.98%1.25M

-155.18%-8.27M

64.63%-8.24M

End cash Position

-88.93%4.15M

-88.56%6.06M

-76.92%11.94M

-69.48%18.32M

-45.16%37.43M

-30.32%53M

-43.59%51.75M

-21.81%60.01M

Free cash flow

79.70%-1.92M

-3.03%-30.34M

-1.92%-7.39M

-3.51%-6.38M

13.43%-7.14M

-21.07%-9.44M

54.55%-29.45M

53.21%-7.25M

38.08%-6.16M

64.66%-8.24M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	79.57%-1.92M	-3.11%-30.14M	-3.58%-7.39M	-3.73%-6.37M	14.47%-7M	-20.73%-9.38M	52.44%-29.23M	52.86%-7.13M	35.84%-6.15M	61.84%-8.19M
Net income from continuing operations	83.26%-1.68M	6.86%-35.14M	14.37%-7.84M	4.24%-8.48M	11.67%-8.77M	-2.66%-10.05M	52.09%-37.73M	22.34%-9.16M	61.07%-8.85M	56.19%-9.93M
Operating gains losses	----	0.00%7K	---5K	--2K	----	----	--7K	----	----	----
Depreciation and amortization	-99.71%2K	-16.09%2.32M	-65.27%241K	-1.74%679K	2.04%699K	1.02%696K	6.24%2.76M	-1.56%694K	2.67%691K	0.88%685K
Other non cash items	----	-0.52%1.33M	25.39%-1.1M	13.57%385K	-30.33%1.46M	54.76%585K	4,203.23%1.33M	-457.52%-1.47M	-0.29%339K	--2.09M
Change In working capital	73.16%-409K	-818.85%-6.25M	-241.42%-2.72M	-180.76%-701K	35.25%-1.31M	-1,655.10%-1.52M	-72.30%870K	131.51%1.92M	-91.12%868K	49.86%-2.02M
-Change in receivables	--0	-99.73%3K	-100.03%-1K	100.14%4K	---4K	-99.64%4K	-68.86%1.11M	626.75%2.91M	-147.60%-2.91M	--0
-Change in prepaid assets	526.53%307K	-256.52%-1.36M	-2,646.00%-1.27M	-193.21%-467K	100.00%334K	-67.11%49K	-90.56%867K	-96.76%50K	-72.56%501K	-93.61%167K
-Change in payables and accrued expense	50.42%-716K	-587.16%-4.76M	14.89%-2.41M	-110.14%-345K	-96.84%-561K	-47.80%-1.44M	93.23%-693K	62.57%-2.83M	65.68%3.4M	93.92%-285K
-Change in other current assets	----	281.68%500K	--0	--500K	----	----	-34.83%131K	--0	--0	135.20%126K
-Change in other current liabilities	--0	-17.71%-638K	-46.42%965K	-214.40%-393K	46.89%-1.08M	30.00%-133K	-224.88%-542K	1,159.41%1.8M	47.70%-125K	-297.47%-2.03M
Cash from discontinued investing activities
Operating cash flow	79.57%-1.92M	-3.11%-30.14M	-3.58%-7.39M	-3.73%-6.37M	14.47%-7M	-20.73%-9.38M	52.44%-29.23M	52.86%-7.13M	35.84%-6.15M	61.84%-8.19M
Investing cash flow
Cash flow from continuing investing activities	0	797.41%1.35M	1,716.13%1.5M	107.14%1K	-136.84%-135K	20.69%-23K	94.19%-193K	74.09%-93K	96.22%-14K	96.96%-57K
Net PPE purchase and sale	--0	797.41%1.35M	1,716.13%1.5M	107.14%1K	-136.84%-135K	20.69%-23K	94.19%-193K	74.09%-93K	96.22%-14K	96.96%-57K
Cash from discontinued investing activities
Investing cash flow	--0	797.41%1.35M	1,716.13%1.5M	107.14%1K	-136.84%-135K	20.69%-23K	94.19%-193K	74.09%-93K	96.22%-14K	96.96%-57K
Financing cash flow
Cash flow from continuing financing activities	0	-384.88%-18.14M	0	0	-11.98M	-6.16M	-75.30%6.37M	4,655.91%8.47M	-108.45%-2.11M	0
Net issuance payments of debt	--0	-117.27%-18.11M	--0	--0	---11.86M	---6.25M	-133.33%-8.33M	---6.25M	---2.08M	--0
Net common stock issuance	--0	-99.37%92K	--0	--0	--0	--92K	--14.68M	--14.72M	---45K	--0
Proceeds from stock option exercised by employees	----	--0	--0	----	----	----	-97.97%21K	--0	----	----
Net other financing activities	----	---125K	--0	--0	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	--0	-384.88%-18.14M	--0	--0	---11.98M	---6.16M	-75.30%6.37M	4,655.91%8.47M	-108.45%-2.11M	--0
Net cash flow
Beginning cash position	-88.56%6.06M	-30.32%53M	-76.92%11.94M	-69.48%18.32M	-45.16%37.43M	-30.32%53M	-33.91%76.05M	-43.59%51.75M	-21.81%60.01M	-31.78%68.26M
Current changes in cash	87.68%-1.92M	-103.55%-46.93M	-570.18%-5.88M	22.90%-6.37M	-131.89%-19.12M	-99.54%-15.56M	40.90%-23.06M	107.98%1.25M	-155.18%-8.27M	64.63%-8.24M
End cash Position	-88.93%4.15M	-88.56%6.06M	-88.56%6.06M	-76.92%11.94M	-69.48%18.32M	-45.16%37.43M	-30.32%53M	-30.32%53M	-43.59%51.75M	-21.81%60.01M
Free cash flow	79.70%-1.92M	-3.03%-30.34M	-1.92%-7.39M	-3.51%-6.38M	13.43%-7.14M	-21.07%-9.44M	54.55%-29.45M	53.21%-7.25M	38.08%-6.16M	64.66%-8.24M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall